What is Commense?
Commense is a biotechnology company focused on developing novel therapeutics derived from a profound understanding of human-microbe interactions. The company's research is particularly centered on the impact of C-section deliveries on infant microbiome development and subsequent long-term health outcomes, including allergies, immune disorders, asthma, and obesity. By seeding newborns with beneficial microbes, Commense aims to mitigate the adverse health effects associated with non-natural birth processes, positioning itself at the forefront of microbiome-based health solutions.
How much funding has Commense raised?
Commense has raised a total of $40M across 1 funding round:
Series B
$40M
Series B (2017): $40M with participation from OrbiMed, Nest Bio, Fidelity Management & Research Company, and Rock Springs Capital
Key Investors in Commense
OrbiMed
OrbiMed is a specialized investment firm with deep expertise in the healthcare sector, managing capital across biopharmaceuticals, medical devices, digital health, and diagnostics. Their investment approach focuses on companies at various stages of development, from early-stage ventures to established organizations.
Nest Bio
Nest.bio operates as a research, development, and venture firm dedicated to transforming breakthrough life sciences and healthcare technologies into revolutionary companies.
Fidelity Management & Research Company
Fidelity Investments is a global provider of financial services and investment resources, assisting individuals and institutions in achieving their financial objectives through a wide range of investment products and services.
What's next for Commense?
With significant enterprise-level backing and a recent strategic investment, Commense is poised for accelerated growth and pipeline development. The substantial capital infusion is expected to fuel further research into its therapeutic candidates, expand clinical trial initiatives, and potentially scale manufacturing capabilities. This strategic financing will likely enable Commense to advance its mission of leveraging microbiome science to address critical health challenges, solidifying its position as a leader in the burgeoning field of microbiome therapeutics.
See full Commense company page
